148 related articles for article (PubMed ID: 34999135)
21. Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinoma.
Martin D; Rödel F; von der Grün J; Rödel C; Fokas E
Radiother Oncol; 2020 Aug; 149():168-173. PubMed ID: 32417344
[TBL] [Abstract][Full Text] [Related]
22. Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.
Meulendijks D; Dewit L; Tomasoa NB; van Tinteren H; Beijnen JH; Schellens JH; Cats A
Br J Cancer; 2014 Oct; 111(9):1726-33. PubMed ID: 25167226
[TBL] [Abstract][Full Text] [Related]
23. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
26. The Role of Multiagent Chemoradiation in the Management and Prognosis of Anal Squamous Cell Carcinoma.
Goffredo P; Utria AF; Hrabe JE; Gribovskaja-Rupp I; Kapadia MR; Hassan I
J Gastrointest Surg; 2019 Apr; 23(4):712-719. PubMed ID: 30644029
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
28. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I
Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.
Wong CS; Tsao MS; Sharma V; Chapman WB; Pintilie M; Cummings BJ
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):309-14. PubMed ID: 10487550
[TBL] [Abstract][Full Text] [Related]
30. VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02).
Feliu J; Garcia-Carbonero R; Capdevila J; Guasch I; Alonso-Orduna V; Lopez C; Garcia-Alfonso P; Castanon C; Sevilla I; Cerezo L; Conill C; Quintana-Angel B; Sanchez ME; Ghanem I; Martin-Richard M; Lopez-Gomez M; Leon A; Caro M; Fernandez T; Maurel J
Cancer Med; 2020 Feb; 9(3):1008-1016. PubMed ID: 31851776
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
Banerjee R; Roxin G; Eliasziw M; Joseph K; Maclean A; Buie WD; Doll C
Dis Colon Rectum; 2013 Sep; 56(9):1036-42. PubMed ID: 23929012
[TBL] [Abstract][Full Text] [Related]
33. Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy.
Wakeham K; Murray L; Muirhead R; Hawkins MA; Sebag-Montefiore D; Brown S; Murphy L; Thomas G; Bell S; Whibley M; Morgan C; Sleigh K; Gilbert DC
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):638-649. PubMed ID: 34024700
[TBL] [Abstract][Full Text] [Related]
34. C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
Martin D; Rödel F; Balermpas P; Winkelmann R; Fokas E; Rödel C
Front Oncol; 2019; 9():1200. PubMed ID: 31788452
[No Abstract] [Full Text] [Related]
35. Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
Gravante G; Stephenson JA; Elshaer M; Osman A; Vasanthan S; Mullineux JH; Gani MAD; Sharpe D; Yeung J; Norwood M; Miller A; Boyle K; Hemingway D
J Surg Oncol; 2018 Feb; 117(2):269-274. PubMed ID: 28891266
[TBL] [Abstract][Full Text] [Related]
36. Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.
Gunderson LL; Moughan J; Ajani JA; Pedersen JE; Winter KA; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett CG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):638-45. PubMed ID: 24035327
[TBL] [Abstract][Full Text] [Related]
37. [Treatment Outcome of Anal Squamous Cell Carcinoma Treated with Radical Chemoradiotherapy].
Sato H; Koide Y; Shiota M; Morise Z; Maeda K; Uyama I
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1708-1710. PubMed ID: 28133106
[TBL] [Abstract][Full Text] [Related]
38. Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.
Wo JY; Plastaras JP; Metz JM; Jiang W; Yeap BY; Drapek LC; Adams J; Baglini C; Ryan DP; Murphy JE; Parikh AR; Allen JN; Clark JW; Blaszkowsky LS; DeLaney TF; Ben-Josef E; Hong TS
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):90-95. PubMed ID: 31128146
[TBL] [Abstract][Full Text] [Related]
39. Review of anal cancer patients at the Ottawa hospital.
Abunassar M; Reinders J; Jonker DJ; Asmis T
Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
[TBL] [Abstract][Full Text] [Related]
40. Predictors of recurrence following local excision for early-stage anal squamous cell carcinoma.
Parkin E; Kallipershad S; Nasser A; Al-Mudhaffer M; Rosero D; Haston J; Williamson D; Mitchell P
Eur J Surg Oncol; 2023 Nov; 49(11):107093. PubMed ID: 37801832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
